Adverse drug reactions related to intravenous immunoglobulin. Analysis of Bordeaux Pharmacovigilance Centre data

被引：0
|
作者：
Daveluy, A [1 ]
Miremont-Salame, G [1 ]
Moore, N [1 ]
Haramburu, F [1 ]
机构：
[1] Univ Victor Segalen, CHU Bordeaux, Dept Pharmacol, Ctr Pharmacovigilance,INSERM U657, Bordeaux, France
来源：
DRUG SAFETY | 2005年 / 28卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
43
引用
收藏
页码：944 / 945
页数：2
相关论文
共 50 条
  • [31] Neonatal adverse drug reactions: an analysis of reports to the French pharmacovigilance database
    Kaguelidou, Florentia
    Beau-Salinas, Frederique
    Jonville-Bera, Annie Pierre
    Jacqz-Aigrain, Evelyne
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (04) : 1058 - 1068
  • [32] Adverse Drug Reactions to β-Lactam Antibiotics: A Portuguese Pharmacovigilance Database Analysis
    Silva, M.
    Fernandes, J. P.
    Parracha, E. Ribeiro
    Gamboa, A.
    Alves, C. Lima
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2024, 34
  • [33] Breastfeeding-Related Adverse Drug Reactions of Triptans: A Descriptive Analysis Using Four Pharmacovigilance Databases
    Conijn, Maartje
    Maas, Veronique
    van Tuyl, Miranda
    Ceulemans, Michael
    Hendriks, Judith
    van Hunsel, Florence
    van der Mijle, Annerose
    BREASTFEEDING MEDICINE, 2024, 19 (08) : 645 - 651
  • [34] Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
    Kheloufi, F.
    Default, A.
    Rouby, F.
    Laugier-Castellan, D.
    Boyer, M.
    Rodrigues, B.
    Ponte-Astoul, J.
    Jean-Pastor, M. J.
    Blin, O.
    Micallef, J.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2017, 73 (08) : 1009 - 1018
  • [35] Online Notifications of Adverse Drug Reactions: A Study in Midi-Pyrenees Pharmacovigilance Regional Centre
    Abadie, D.
    Bert, M.
    Durrieu, G.
    Montastruc, J.
    DRUG SAFETY, 2011, 34 (10) : 990 - 990
  • [36] Informativeness of patient initial reports of adverse drug reactions. Can it be improved by a pharmacovigilance centre?
    F Kheloufi
    A Default
    F Rouby
    D Laugier-Castellan
    M Boyer
    B Rodrigues
    J Ponte-Astoul
    MJ Jean-Pastor
    O Blin
    J Micallef
    European Journal of Clinical Pharmacology, 2017, 73 : 1009 - 1018
  • [37] Dermatological adverse drug reactions of anticancer drugs: International data of pharmacovigilance: VigiBase
    Strumia, Mathilde
    Perrin, Marie-Loup
    de Compaigno, Emilie Patras
    Conte, Cecile
    Montastruc, Francois
    Lapeyre-Mestre, Maryse
    Sibaud, Vincent
    Despas, Fabien
    THERAPIE, 2022, 77 (02): : 219 - 227
  • [38] Adverse Reactions and Pathogen Safety of Intravenous Immunoglobulin
    Carbone, Javier
    CURRENT DRUG SAFETY, 2007, 2 (01) : 9 - 18
  • [39] Pattern of adverse drug reactions in Nigerian children with HIV: Evidence from the Nigerian Pharmacovigilance Centre
    Etuk, Victoria
    Adeoye, Ikeola
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 426 - 426
  • [40] Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database
    Ruggiero, Rosanna
    Fraenza, Federica
    Scavone, Cristina
    di Mauro, Gabriella
    Piscitelli, Raffaele
    Mascolo, Annamaria
    Ferrajolo, Carmen
    Rafaniello, Concetta
    Sportiello, Liberata
    Rossi, Francesco
    Capuano, Annalisa
    FRONTIERS IN PHARMACOLOGY, 2020, 11
12345